Pharmaceutical company Galderma is hosting a launch event for its new liquid neuromodulator Alluzience.
Following a soft launch in 2022, Alluzience has been tried in selected practices across the UK and Ireland and is now available to purchase at Medfx in the UK and BFM in Ireland.
The launch event will be invite only for in-person guests but will be live-streamed for registered healthcare professionals to watch. The full agenda is still to be confirmed but will be taking place on March 9 at 8 Northumberland Avenue, London with doors opening at 4:30pm and being held between 5pm-7pm GMT.
Galderma will be revealing more details about
Alluzience at ACE, with a spot on the Symposium Agenda at 12:30 on March 11. Register here for free now.